Cerence CRNC posted a 14.45% decrease in earnings from Q1. Sales, however, increased by 3.89% over the previous quarter to $98.66 million. Despite the increase in sales this quarter, the decrease in earnings may suggest Cerence is not utilizing their capital as effectively as possible. Cerence reached earnings of $20.27 million and sales of $94.96 million in Q1.
What Is Return On Capital Employed?
Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q2, Cerence posted an ROCE of 0.02%.
Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future.
ROCE is an important metric for the comparison of similar companies. A relatively high ROCE shows Cerence is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and earnings per share growth.
In Cerence's case, the positive ROCE ratio will be something investors pay attention to before making long-term financial decisions.
Q2 Earnings Recap
Cerence reported Q2 earnings per share at $0.69/share, which beat analyst predictions of $0.52/share.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.